Longevity PapersAbout
← All papers
RESEARCH PAPER / 2026-06-23

Disorders of Telomere Length.

Kristen E Schratz, Mary Armanios

Department of Oncology and Telomere Center at Johns Hopkins, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA.Department of Oncology and Telomere Center at Johns Hopkins, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA. · pubmed

Abstract

AbstractRecent discoveries have uncovered roles for telomere length, at both short and long extremes, as a driver of inherited disease risk in children and adults. For short telomere length the predominant phenotype is degenerative, with immunodeficiency, bone marrow failure, and pulmonary disease being most common. Short telomere syndrome genetics inform clinical decisions and have transformed understanding of the etiology, natural history, and treatment of common diseases such as idiopathic pulmonary fibrosis. At the other extreme, ultra-long telomere length predisposes to neoplasia including lympho- and myeloproliferative disease. Individuals with mutations that lengthen telomeres may show features of youthfulness such as delayed hair graying but paradoxically are at risk for benign and malignant neoplasia, which are associated with aging. Their earliest events are traceable in the blood as premature onset of clonal hematopoiesis which shows complete penetrance with aging. Here, we review the genetic basis, pathophysiology, and contrasting phenotypes of Mendelian short and long telomere syndromes, emphasizing how they inform clinical decisions as well as our understanding of the fundamentals of aging and cancer.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

This paper reviews how genetic disorders of telomere length provide mechanistic insights into the fundamental biology of aging and cancer, linking telomere maintenance to both degenerative disease and neoplasia. The review synthesizes existing knowledge on Mendelian syndromes to inform clinical understanding rather than presenting new experimental data or proposing a novel longevity intervention.

Author of this paper? Send a correction.